Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: General Cardiologists (US)

Council Members in this Study Group: 1333

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Harold Bays, MD, President and Medical Director, L-MARC Research CenterHarold Bays, MD

President and Medical Director
L-MARC Research Center
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Harold Bays, MD, FACP, FACE, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all marketed lipid-altering drug treatments, as well...

Daniel Fisher, MD, FACC, FACP

Cardiologist
NEW YORK UNIVERSITY (INC)
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Daniel Fisher, MD, FACC, FACP, is a Cardiologist at NYU Medical Center. He has a private practice in Cardiology and specializes in non-invasive cardiology. Dr. Fisher is board certified in Internal Medicine, Cardiovascular Diseases, and Nuclear Cardiology. He has lectured frequently on such topicsas...

Howard Weintraub, MD

Clinical Director
NEW YORK UNIVERSITY (INC)
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Howard Weintraub, MD, FACC, is the Clinical Director of Center for the Prevention of Cardiovascular Disease at NYU Medical Center. He has been a consultant for several organizations and has been a Cardiologist for the National Football League. Dr. Weintraub has written textbook chapters on evaluation...

Dan Streja, MD

Clinical Professor of Medicine
UNIVERSITY OF CALIFORNIA, LOS ANGELES
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA Medical Center of West Los Angeles. Dr. Streja has...

Carlos Dujovne, MD, Professor of Medicine and Director, OREGON HEALTH & SCIENCE UNIVERSITY - CCCarlos Dujovne, MD

Professor of Medicine and Director
OREGON HEALTH & SCIENCE UNIVERSITY - CC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Carlos Dujovne is the Professor of Medicine, the Chairman of Kansas Foundation for Clinical Pharmacology and Therapeutics (KFCPT), Cardiovascular Division and the Director of Clinical Cardiovascular and Metabolic Risk Treatment Programs at Oregon Health and Science University, in Portland, since July...

Joshua Feuer, MD

Owner
JOSHUA M FEUER
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Joshua Feuer, MD, FACC, is a board certified Cardiologist in solo private practice in Santa Barbara, California. He also serves as a Consulting Cardiologist at Santa Barbara Cottage Hospital. Dr. Feuer specializes in aggressive preventive cardiology and cardiovascular risk assessment and reduction....

Charles Glueck, MD, Medical Research Director of Cholesterol Center, Jewish HospitalCharles Glueck, MD

Medical Research Director of Cholesterol Center
Jewish Hospital
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Charles Glueck, MD, is the Medical Director of Jewish Hospital Cholesterol Center in Cincinnati, Ohio. He has expertise in lipids, lipoproteins, interaction of atherosclerosis and thrombosis, thrombosis, human genetics, epidemiology, obstetrics and gynecology, and hematology. Dr Glueck and colleagues...

Bernard Chaitman, MD, Professor and Director, SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINEBernard Chaitman, MD

Professor and Director
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Bernard Chaitman, MD, is Professor of Internal Medicine and Director of Cardiovascular Research at the St. Louis University School of Medicine in Missouri. He is also the Director of the Core ECG Laboratory. Dr. Chaitman has research interests in anti-anginal drug therapies, including Ranolazine, Nicorandil,...

View all Leading Experts in this Study Group

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Ghana Targets Health Tourism Boom: More Evidence of Globalization

October 31, 2009

Ghana targets health tourism boom | news.bbc.co.uk

Just as high tech products are manufactured in Asian countries for a fraction of the cost, medical procedures will be provided in less developed countries for a fraction of the cost in the not so distant future.It will initially be low tech procedures such as cosmetic operations and minor procedures...

We need to learn more about ProSavin Phase I/II Trial in Parkinson’s disease

October 20, 2009

Oxford BioMedica Announces Update on ProSavin® Phase I/II Trial in Parkinsons Disease And Publication of Preclinical Results | www.pipelinereview.com

This is very interesting news. However, in my judgment it is too early to make a final conclusion concerning this clinical trial. Because it should be taken into account that the growing body of evidence clearly indicates that oxidative stress induced mitochondrial failure appeared to be one of the...

Amyloid Beta does not correlate to Alzheimer Disease.

October 12, 2009

Bayer Schering ties-up with AC Immune for trial in Alzheimer´s disease | www.pharmabiz.com

The finding of amyloid-beta (Aβ) deposition in AD brains after death led to the so-called “amyloid hypothesis”.  We have extensively reviewed the literature which claims that AD is caused by the deposition of Aβ within structures called senile plaques that invade AD brains and that such plaque formation...

Metanalyses, Metapsychoses

September 30, 2009

Ronald Innerfield, MD, Vice President of Clinical Affairs, Evidence Based Medicine, Inc.

Controls to blood sugar 'cuts stroke risk' | www.barchester.com

There have been many epidemiologic studies showing a very tight correlation between baseline A1c and cardiovascular mortalityDespite this, five major randomized prospective studies have failed to show any macrovascular benefit for tighter glucose controlThe logical conclusion is that glucose is, therefore,...

The Logical Next Step for Abbott

September 15, 2009

Abbott To Acquire Evalve, Inc., A Leader In Minimally Invasive Cardiac Valve Repair Technology | www.medicalnewstoday.com

With this acquisition Abbott establishes its position as a major player in the field of interventional cardiology and treatment of structural heart disease.The field of structural heart disease therapy is the fastest growing area of interventional cardiology and Abbott is getting in at the ground floor.In...

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • Physician - Division Head
  • Partner
  • Director
  • President

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in General Cardiologists (US) Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

GLG Webcasts

Leading Experts in General Cardiologists (US) have not participated in any GLG webcasts.

View All GLG Webcasts in Healthcare